Removing Another Barrier to Addressing GI Tract Diseases With A New Ingestible Capsule
It is our expectation that this manufacturing approach will widen the design paradigm of developing minimally invasive micro/nano/bio devices and systems
Stay updated with breaking news from Actuators Laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It is our expectation that this manufacturing approach will widen the design paradigm of developing minimally invasive micro/nano/bio devices and systems
Diagnosing and treating gastrointestinal tract diseases can be notoriously invasive and time-consuming: blood and stool lab work; biopsies, colonoscopies and endoscopies; and X-rays, CT scans and MRI imaging. But what if there was an alternative as s
© Félix Wey, Werner Siemens Stiftung / 2021 EPFL Engineers at EPFL’s Center for Artificial Muscles have developed a silicone aorta that can reduce how hard patients’ hearts have to pump. Their breakthrough could offer a promising alternative to heart transplants. “Over 23 million people around the world suffer from heart failure. The disease is usually treated with a transplant, but because donated hearts are hard to come by, there is an ongoing need for alternative therapies. With new developments in cardiac assistance systems, we can delay the need for a transplant – or even elimi...